全文获取类型
收费全文 | 10881篇 |
免费 | 444篇 |
国内免费 | 57篇 |
专业分类
耳鼻咽喉 | 38篇 |
儿科学 | 217篇 |
妇产科学 | 103篇 |
基础医学 | 1163篇 |
口腔科学 | 203篇 |
临床医学 | 746篇 |
内科学 | 2748篇 |
皮肤病学 | 136篇 |
神经病学 | 814篇 |
特种医学 | 401篇 |
外科学 | 2010篇 |
综合类 | 44篇 |
预防医学 | 239篇 |
眼科学 | 560篇 |
药学 | 634篇 |
中国医学 | 24篇 |
肿瘤学 | 1302篇 |
出版年
2023年 | 41篇 |
2022年 | 83篇 |
2021年 | 157篇 |
2020年 | 81篇 |
2019年 | 146篇 |
2018年 | 170篇 |
2017年 | 150篇 |
2016年 | 217篇 |
2015年 | 201篇 |
2014年 | 271篇 |
2013年 | 320篇 |
2012年 | 520篇 |
2011年 | 542篇 |
2010年 | 350篇 |
2009年 | 277篇 |
2008年 | 518篇 |
2007年 | 570篇 |
2006年 | 573篇 |
2005年 | 580篇 |
2004年 | 599篇 |
2003年 | 541篇 |
2002年 | 571篇 |
2001年 | 333篇 |
2000年 | 360篇 |
1999年 | 320篇 |
1998年 | 156篇 |
1997年 | 128篇 |
1996年 | 113篇 |
1995年 | 88篇 |
1994年 | 102篇 |
1993年 | 91篇 |
1992年 | 210篇 |
1991年 | 182篇 |
1990年 | 165篇 |
1989年 | 187篇 |
1988年 | 166篇 |
1987年 | 104篇 |
1986年 | 139篇 |
1985年 | 130篇 |
1984年 | 90篇 |
1983年 | 83篇 |
1979年 | 78篇 |
1978年 | 48篇 |
1977年 | 49篇 |
1974年 | 48篇 |
1973年 | 50篇 |
1972年 | 45篇 |
1971年 | 59篇 |
1969年 | 43篇 |
1968年 | 46篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Kei Kamide Yoshihiro Kokubo Hironori Hanada Junko Nagura Jin Yang Shin Takiuchi Chihiro Tanaka Mariko Banno Yoshikazu Miwa Masayoshi Yoshii Tetsutaro Matayoshi Hisayo Yasuda Takeshi Horio Akira Okayama Hitonobu Tomoike Yuhei Kawano Toshiyuki Miyata 《Hypertension research》2006,29(4):243-252
Mutations in the gene encoding 11beta-hydroxysteroid dehydrogenase type 2, HSD11B2, cause a rare monogenic juvenile hypertensive syndrome called apparent mineralocorticoid excess (AME). In AME, defective HSD11B2 enzyme activity results in overstimulation of the mineralocorticoid receptor (MR) by cortisol, causing sodium retention, hypokalemia, and salt-dependent hypertension. Here, we have studied whether genetic variations in HDS11B2 are implicated in essential hypertension in Japanese hypertensives and the general population. By sequencing the entire coding region and the promoter region of HDS11B2 in 953 Japanese hypertensives, we identified five missense mutations in 11 patients (L14F, n = 5; R74H, n = 1; R147H, n = 3; T156I, n = 1; R335H, n = 1) and one novel frameshift mutation (4884Gdel, n = 1) in a heterozygous state, in addition to 19 genetic variations. All genetic variations identified were rare, with minor allele frequencies less than 0.005. Four of 12 patients with the missense/frameshift mutations showed renal failure. Four missense mutations, L14F, R74H, R147H, and R335H, were successfully genotyped in the general population, with a sample size of 3,655 individuals (2,175 normotensives and 1,480 hypertensives). Mutations L14F, R74H, R147H, and R335H were identified in hypertensives (n = 6, 8, 3, and 0, respectively) and normotensives (n = 8, 12, 5, and 0, respectively) with a similar frequency, suggesting that these missense mutations may not strongly affect the etiology of essential hypertension. Since the allele frequency of all of the genetic variations identified in this study was rare, an association study was not conducted. Taken together, our results indicate that missense mutations in HSD11B2 do not substantially contribute to essential hypertension in Japanese. 相似文献
2.
Kazunori Aizawa Takeshi Hanaoka Hiroki Kasai Kaoru Kogashi Setsuo Kumazaki Jun Koyama Hiroshi Tsutsui Yoshikazu Yazaki Noboru Watanabe Osamu Kinoshita Uichi Ikeda 《Hypertension research》2006,29(2):123-128
The phosphodiesterase-5 (PDE-5) inhibitor, sildenafil, has been reported to produce sustained pulmonary vasodilatation in patients with pulmonary hypertension (PH). Recently, vardenafil, a more potent and selective PDE-5 inhibitor than sildenafil, has been approved for the treatment of erectile dysfunction. However, the long-term effects of oral vardenafil in patients with PH are unknown. We studied five consecutive patients with PH; one with primary pulmonary hypertension, two with chronic pulmonary thromboembolism, one with Eisenmenger syndrome (ventricular septal defect) and one with secondary pulmonary hypertension after a ventricular septal defect closure operation. In an acute hemodynamic trial, vardenafil (5 mg) significantly decreased both the pulmonary vascular resistance (PVR) and systemic vascular resistance (SVR) with an increase in cardiac output. In a chronic hemodynamic trial, the maintenance dose of vardenafil (10 to 15 mg) for 3 months significantly decreased the PVR, but not the SVR, with a 20.7% reduction of the PVR/ SVR ratio. Plasma brain natriuretic peptide (BNP) levels were also significantly decreased after 3 months. This pilot study demonstrates that long-term oral vardenafil therapy may be a safe and effective treatment for patients with PH. 相似文献
3.
Shoji Kubo Hiroaki Kinoshita Kazuhiro Hirohashi Takatsugu Yamamoto 《Journal of Hepato-Biliary-Pancreatic Surgery》1995,2(1):85-89
A case of cystadenocarcinoma of the liver is reported. The patient was a 73-year-old woman in whom a tumor was detected in
the lateral segment of the liver during a health examination. Ultrasonograms and computed tomograms showed a multilocular
cystic mass. Magnetic resonance imaging (MRI) showed a multilocular lowintensity mass, including a high-intensity portion
and a portal branch compressed by the tumor. MRI with gadolinium showed an enhanced cyst wall. The cystic part of the tumor
became smaller and the solid part became larger over a 1-month period, indicating that the tumor was malignant. Subsegmentectomy
(S3) was performed and cystadenocarcinoma with cystadenoma was diagnosed by histopathological examination. Identification of
changes in the appearance of a tumor should be helpful for the differential diagnosis of cystadenoma and cystadenocarcinoma. 相似文献
4.
Basic fibroblast growth factor prevents thalamic degeneration after cortical infarction 总被引:10,自引:0,他引:10
K Yamada A Kinoshita E Kohmura T Sakaguchi J Taguchi K Kataoka T Hayakawa 《Journal of cerebral blood flow and metabolism》1991,11(3):472-478
In the focal infarction model of the rat middle cerebral artery (MCA), the thalamus of the occluded side becomes gradually atrophic, mainly because of retrograde degeneration. We determined whether basic fibroblast growth factor (bFGF) administered intracisternally could prevent this thalamic atrophy. We occluded the left MCA through a small cranial opening, and animals were then divided into two groups. One group received intracisternal injections of recombinant bFGF (1 microgram dissolved in 0.1 ml of saline with 2% rat serum) starting 1 day after occlusion and repeated once a week to a total dose of 4 micrograms by four injections. The other group received vehicle solution by the same schedule. The animals were perfused and fixed at 28 days after occlusion, and histological examination was made at the level of the caudoputamen and thalamus. In the bFGF-treated rats, the area of the posterior ventral thalamus of the occluded side was 93% of that of the contralateral side, i.e., significantly larger than in the normal saline-treated rats (75%, p less than 0.01). The infarction size was not statistically different in the two groups. Microscopic observation indicated that normal-saline-treated animals showed shrinkage and disappearance of thalamic neurons, whereas bFGF-treated groups showed preservation of thalamic neurons. Computerized analysis of the cell size substantiated this observation. To assess the effect of bFGF on astrocytes, bFGF or vehicle solution was injected into normal rats, and their histology was evaluated at 1, 2, and 4 weeks after injection. The bFGF-injected group showed a significant increase in glial fibrillary acidic protein-positive astrocytes in the brain tissue facing the ventriculocisternal system.(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献
5.
6.
7.
8.
9.
Naoharu Iwai Tadashi Inagami Masahiko Kinoshita 《Clinical and experimental pharmacology & physiology》1994,21(11):913-914
1. We have recently identified a candidate gene for rat genetic hypertension, termed Sa, by identifying an mRN A species that shows markedly higher expression in the kidneys of spontaneously hypertensive rats (SHR) than in those of Wistar-Kyoto rats (WKY). 2. Subsequent genetic co-segregation analyses by ourselves and others indicated that the Sa gene locus did indeed influence blood pressure. Moreover, in a preliminary association study, we found an association of a polymorphism of the human Sa gene with essential hypertension. 3. Further studies to identify functions of the Sa gene products are required before reaching a definite conclusion. 相似文献
10.